Researchers can more accurately control the dose-response relationships in their experiments, leading to clearer interpretation of results and better grasp of IGF-1 receptor-mediated effects
But rapid weight loss whether achieved by using the medications, dieting or losing weight unintentionally comes with multiple physical consequences
Doctronic offers personalized guidance on meal timing and portion sizes based on individual symptom patterns
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
best results come when medication is paired with therapy, relapse-prevention planning, and support
Butyrate: a double-edged sword for health
